402 related articles for article (PubMed ID: 22859999)
1. Altered A-to-I RNA editing in human embryogenesis.
Shtrichman R; Germanguz I; Mandel R; Ziskind A; Nahor I; Safran M; Osenberg S; Sherf O; Rechavi G; Itskovitz-Eldor J
PLoS One; 2012; 7(7):e41576. PubMed ID: 22859999
[TBL] [Abstract][Full Text] [Related]
2. Alu sequences in undifferentiated human embryonic stem cells display high levels of A-to-I RNA editing.
Osenberg S; Paz Yaacov N; Safran M; Moshkovitz S; Shtrichman R; Sherf O; Jacob-Hirsch J; Keshet G; Amariglio N; Itskovitz-Eldor J; Rechavi G
PLoS One; 2010 Jun; 5(6):e11173. PubMed ID: 20574523
[TBL] [Abstract][Full Text] [Related]
3. Specificity of ADAR-mediated RNA editing in newly identified targets.
Riedmann EM; Schopoff S; Hartner JC; Jantsch MF
RNA; 2008 Jun; 14(6):1110-8. PubMed ID: 18430892
[TBL] [Abstract][Full Text] [Related]
4. Evolutionarily conserved human targets of adenosine to inosine RNA editing.
Levanon EY; Hallegger M; Kinar Y; Shemesh R; Djinovic-Carugo K; Rechavi G; Jantsch MF; Eisenberg E
Nucleic Acids Res; 2005; 33(4):1162-8. PubMed ID: 15731336
[TBL] [Abstract][Full Text] [Related]
5. ADAR1 is involved in the regulation of reprogramming human fibroblasts to induced pluripotent stem cells.
Germanguz I; Shtrichman R; Osenberg S; Ziskind A; Novak A; Domev H; Laevsky I; Jacob-Hirsch J; Feiler Y; Rechavi G; Itskovitz-Eldor J
Stem Cells Dev; 2014 Mar; 23(5):443-56. PubMed ID: 24192045
[TBL] [Abstract][Full Text] [Related]
6. Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease.
Vlachogiannis NI; Sachse M; Georgiopoulos G; Zormpas E; Bampatsias D; Delialis D; Bonini F; Galyfos G; Sigala F; Stamatelopoulos K; Gatsiou A; Stellos K
J Mol Cell Cardiol; 2021 Nov; 160():111-120. PubMed ID: 34302813
[TBL] [Abstract][Full Text] [Related]
7. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
[TBL] [Abstract][Full Text] [Related]
8. Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing.
George CX; Wagner MV; Samuel CE
J Biol Chem; 2005 Apr; 280(15):15020-8. PubMed ID: 15677478
[TBL] [Abstract][Full Text] [Related]
9. Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms.
Sun T; Yu Y; Wu X; Acevedo A; Luo JD; Wang J; Schneider WM; Hurwitz B; Rosenberg BR; Chung H; Rice CM
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723056
[TBL] [Abstract][Full Text] [Related]
10. A survey on cellular RNA editing activity in response to Candida albicans infections.
Huang Y; Cao Y; Li J; Liu Y; Zhong W; Li X; Chen C; Hao P
BMC Genomics; 2018 Jan; 19(Suppl 1):43. PubMed ID: 29363428
[TBL] [Abstract][Full Text] [Related]
11. Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis.
Liddicoat BJ; Hartner JC; Piskol R; Ramaswami G; Chalk AM; Kingsley PD; Sankaran VG; Wall M; Purton LE; Seeburg PH; Palis J; Orkin SH; Lu J; Li JB; Walkley CR
Exp Hematol; 2016 Oct; 44(10):947-63. PubMed ID: 27373493
[TBL] [Abstract][Full Text] [Related]
12. ADAR1-mediated 3' UTR editing and expression control of antiapoptosis genes fine-tunes cellular apoptosis response.
Yang CC; Chen YT; Chang YF; Liu H; Kuo YP; Shih CT; Liao WC; Chen HW; Tsai WS; Tan BC
Cell Death Dis; 2017 May; 8(5):e2833. PubMed ID: 28542129
[TBL] [Abstract][Full Text] [Related]
13. A-to-I editing of coding and non-coding RNAs by ADARs.
Nishikura K
Nat Rev Mol Cell Biol; 2016 Feb; 17(2):83-96. PubMed ID: 26648264
[TBL] [Abstract][Full Text] [Related]
14. RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.
Kim JI; Nakahama T; Yamasaki R; Costa Cruz PH; Vongpipatana T; Inoue M; Kanou N; Xing Y; Todo H; Shibuya T; Kato Y; Kawahara Y
PLoS Genet; 2021 May; 17(5):e1009516. PubMed ID: 33983932
[TBL] [Abstract][Full Text] [Related]
15. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
[TBL] [Abstract][Full Text] [Related]
16. Increased adenosine-to-inosine RNA editing in rheumatoid arthritis.
Vlachogiannis NI; Gatsiou A; Silvestris DA; Stamatelopoulos K; Tektonidou MG; Gallo A; Sfikakis PP; Stellos K
J Autoimmun; 2020 Jan; 106():102329. PubMed ID: 31493964
[TBL] [Abstract][Full Text] [Related]
17. RNA-Editing Enzyme ADAR1 p150 Isoform Is Critical for Germinal Center B Cell Response.
Li Y; Ruan GX; Chen W; Huang H; Zhang R; Wang J; Li Y; Xu S; Ou X
J Immunol; 2022 Sep; 209(6):1071-1082. PubMed ID: 35977796
[TBL] [Abstract][Full Text] [Related]
18. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
Qin YR; Qiao JJ; Chan TH; Zhu YH; Li FF; Liu H; Fei J; Li Y; Guan XY; Chen L
Cancer Res; 2014 Feb; 74(3):840-51. PubMed ID: 24302582
[TBL] [Abstract][Full Text] [Related]
19. RNA editing of AZIN1 coding sites is catalyzed by ADAR1 p150 after splicing.
Xing Y; Nakahama T; Wu Y; Inoue M; Kim JI; Todo H; Shibuya T; Kato Y; Kawahara Y
J Biol Chem; 2023 Jul; 299(7):104840. PubMed ID: 37209819
[TBL] [Abstract][Full Text] [Related]
20. Adenosine Deaminase Acting on RNA (ADAR) Enzymes: A Journey from Weird to Wondrous.
Keegan LP; Hajji K; O'Connell MA
Acc Chem Res; 2023 Nov; 56(22):3165-3174. PubMed ID: 37906879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
